2015-2019 Spanish Genetic Diseases, Cancer, Forensic and Paternity Molecular Diagnostic Testing Markets: Country Forecasts, Emerging Technologies, Competitive Strategies

September 2015 | 407 pages | ID: 2A114143F56EN
Venture Planning Group

Abstracts

Complete report $1,850. DataPack (test volumes, sales forecasts, supplier shares) $1,200. The report is available by section, market segment, and can be custom-tailored to your specific information needs and budget.

This new study from VPGMarketResearchcontains 407 pages, and is designed to help current suppliers and potential market entrants identify and evaluate emerging opportunities for molecular diagnostic technologies and products in testing for genetic diseases, cancer, as well a forensic and paternity/HLA typing applications during the next five years.

Report Highlights

• Market shares of leading suppliers
• Business and technological trends in major markets
• Five-year test volume and sales forecasts
• Market shares of leading competitors
• Feature comparison of major analyzers
• Strategic profiles of leading market players and start-up firms developing innovative products
• Specific product and business opportunities for instrument and consumable suppliers.

Rationale

Genetic Diseases, Cancer, Forensic and Paternity molecular diagnostic testing markets are among the most rapidly growing segments of the in vitro diagnostics industry. The next five years will witness significant developments in reagent systems and automation, as well as introduction of a wide range of new products that will require innovative marketing approaches. The rate of market penetration into routine clinical laboratories, however, will depend on the introduction of cost-effective and automated systems with amplification methods. In order to successfully capitalize on the opportunities presented by these markets, many companies are already exploiting new molecular technologies as corporate strategic assets, managed in support of business and marketing strategies. Integrating new technology planning with business and corporate strategies will be one of the most challenging tasks for diagnostic companies during the next five years.

Spain Market Overview

• Laboratories performing DNA sequencing and molecular diagnostic testingby country and market segment.
• Five-year test volume and sales projections.

Market Segmentation Analysis

• Five-year test volume and sales projections:
• Infectious Diseases - Forensic Testing
• Cancer - Paternity Testing/HLA Typing
• Genetic Diseases - Others
• A comprehensive analysis of the sequencing market by laboratory segment.
• Detailed market segmentation analysis, including review of the market dynamics, trends, structure, size, growth and major suppliers.

Product/Technology Review

• Comparison of the major molecular diagnosticanalyzers.
• Extensive review of molecular diagnostic technologies, test formats, detection methodologies, trends in testing automation and over target/signal amplification methods.
• Worldwide listings of companies, universities and research centers developing new molecular diagnostictechnologies and products.

Competitive Assessments

Extensive strategic assessments of major suppliers and emerging market entrants, including their sales, product portfolios, marketing tactics, collaborative arrangements and new technologies/products in R&D.

• Abbott
• Affymetrix
• Agilent Technologies
• Applied Gene Technologies
• Arca Biopharma
• Beckman Coulter/Danaher
• Becton Dickinson
• Biokit
• BioMerieux
• Bio-Rad
• Biotest
• Cepheid
• CellMark Forensics Lab/Corp
• Decode Genetics
• Diadexus
• Eiken
• Elitech Group
• Enzo
• Exact Sciences
• Fujirebio
• Grifols
• Hologic/Gen-Probe
• Illumina
• Kreatech/Leica
• Li-Cor Biosciences
• Monogram Biosciences
• Myriad Genetics
• Ortho-Clinical Diagnostics
• Perkin Elmer/Caliper
• Proteome Sciences
• Qiagen
• Roche
• Scienion
• Sequenom
• Shimadzu
• Siemens
• Sierra Molecular
• Takara Bio
• Tecan Group
• Thermo Fisher

Comprehensive listings of companies developing and marketing molecular diagnostic products, by test and application.

Opportunities and Strategic Recommendations

• Specific new product development opportunities with potentially significant market appeal during the next five years.
• Design criteria for new products.
• Alternative market penetration strategies.
• Potential market entry barriers and risks.
• Business planning issues and concerns.

Contains 407 pages

Contents

INSTRUMENTATION REVIEW

HEMATOLOGY ANALYZERS

OVERVIEW

      Electrical ApertureImpedance Analyzers
      Light Scatter Analyzers
SYSTEM REVIEW
Abbott CellDyn 1800
Abbott CellDyn 3000
Abbott CellDyn 3200
Abbott CellDyn 3500
Abbott CellDyn 3700
Abbott CellDyn Ruby
Abbott CellDyn Sapphire
Abbott CellDyn Emerald
Beckman Coulter Ac?T diff
Beckman Coulter Ac?T diff2
Beckman Coulter HmX
Beckman Coulter LH
Beckman Coulter LH
Beckman Coulter LH
Beckman Coulter LH 1500
Beckman Coulter STKS
Beckman Coulter UniCell DxH
Biocode Hycel Celly Plus
Biocode Hycel 9000
DrewScientific 2280
DrewScientific Excell 16 and
Horiba ABX Helios LMG/5DIFF
Horiba ABX Micros Series
Horiba ABX Pentra Series
Menarini BC Series
Nihon Kohden MEK Series
Siemens ADVIA/H Series
Siemens Advia
Siemens Advia 2120i
Sysmex XE2100
Sysmex XE5000
Sysmex XEAlphaN
Sysmex HSTN
Sysmex NE8000
Sysmex pocH100i
Sysmex SE9000
Sysmex VESMatic Cube
Sysmex XT Series
FLOW CYTOMETERS
INTRODUCTION
SYSTEM OVERVIEW
BD FACSadvantage
BD FACSAria III
BD FACSCalibur
BD FACScan
BD FACSCanto II
BD FACSCount
BD FACSort
BD FACStar Series
BD FACStrak
BD FACS Vantage
BD Influx
Beckman Coulter Epics C
Beckman Coulter Epics Elite Analyzer
Beckman Coulter Epics Elite ESP
Beckman Coulter Epics Profile
Beckman Coulter Epics XL
Beckman Coulter FC 500 Series
Beckman Coulter ViCELL XR
PLATELET AGGREGOMETERS
SEDIMENTATION RATE ANALYZERS
      Diesse Ves Matic
Polymedco Sedimat

COMPETITIVE ASSESSMENTS

Abbott
Beckman Coulter/Danaher
Becton Dickinson
BioRad
CellaVision
Dako
Horiba
Iris
Nihon Kohden
OrthoClinical Diagnostics
Roche
Siemens
Sysmex